The combination of two kinase inhibitors effective against metastatic melanoma could provide a systemic alternative to existing local treatments, such as radiation and surgery, for brain metastasis, according to authors of a recently published study.
In this article the authors review the role of imaging for patients with melanoma in the era of effective systemic therapies and discuss likely future developments.
The better concordance achieved by physicians treating >30 melanomas per year suggests that a minimum caseload threshold for physicians treating melanoma patients would be desirable, according to authors of this study in New South Wales.
Two rare and deadly forms of melanoma are not caused by sun exposure new genetic research led by Australian researchers reveals today. Published in Nature, the study shows that acral melanomas found on the palms, soles of the feet and under the nails, and mucosal melanomas found on the body’s internal surfaces, are not linked to ultraviolet (UV) radiation.
This article provides an overview of the evidence of tanning addiction and a systematic review of existing tanning interventions with the goal of evaluating their potential to impact addicted tanners.
This article highlights the recent global trends in the epidemiology of skin cancer, risk factors and the impact of skin cancer on health services. It also highlights the need for improved registration policies as well as primary and secondary prevention strategies.
The rapid advancement in genetic technology and evolving approaches to data set analyses should lead to better outcomes for patients with melanoma, according to authors of this review article.
This study explores how culture-based meanings and values towards skin colour profoundly influence women’s leisure behaviours, including sun-seeking, sun-avoidance and sun protection behaviours.
Despite novel approaches of combination treatments, resistance to combination therapies is rapid and common, according to authors of this recent review. They conclude that new treatment strategies may require triple or more complex drug combinations.
This highly focused one-day event will feature Australia and New Zealand’s top experts in melanoma epidemiology, treatment, clinical trials and scientific research. Organised by MelNet and Melanoma New Zealand in partnership with the Queenstown Research Week (QRW), this is a must attend event for clinicians and scientists with a commitment to improving outcomes for patients with melanoma in New Zealand.